Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers.
Godfrey EM, Magaret A, Roe A, Taylor-Cousar JL, Walker P, Langfelder-Schwind E, Kazmerski TM, Jain R, Mody SK, Uluer A, West NE, Bray LA, Hsu C, Fiastro A, Stukovsky KDH, Hadjiliadis D, Solomon GM, Ladores-Barrett S. Godfrey EM, et al. Among authors: taylor cousar jl. J Cyst Fibros. 2025 Jan 22:S1569-1993(25)00006-2. doi: 10.1016/j.jcf.2025.01.007. Online ahead of print. J Cyst Fibros. 2025. PMID: 39848844
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol.
Liu CM, Fischer JL, Zemanick ET, Woods JC, Markarian KK, Fain SB, Froh D, Heltshe SL, Hoffman LR, Humphries SM, Kramer EL, Ode KL, Lewis M, Li DA, Mata J, Milla SS, Niedbalski PJ, Sawatzky BD, Sim MS, Sullivan JS, Trout AT, Goss CH, Taylor-Cousar JL, Beswick DM. Liu CM, et al. Among authors: taylor cousar jl. ERJ Open Res. 2025 Jan 13;11(1):00137-2024. doi: 10.1183/23120541.00137-2024. eCollection 2025 Jan. ERJ Open Res. 2025. PMID: 39811548 Free PMC article.
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G. Hoppe JE, et al. Among authors: taylor cousar jl. Lancet Respir Med. 2024 Dec 20:S2213-2600(24)00407-7. doi: 10.1016/S2213-2600(24)00407-7. Online ahead of print. Lancet Respir Med. 2024. PMID: 39756425 Free article.
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A. Keating C, et al. Among authors: taylor cousar jl. Lancet Respir Med. 2024 Dec 20:S2213-2600(24)00411-9. doi: 10.1016/S2213-2600(24)00411-9. Online ahead of print. Lancet Respir Med. 2024. PMID: 39756424 Free article.
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment.
Zemanick ET, Ramsey B, Sands D, McKone EF, Fajac I, Taylor-Cousar JL, Mall MA, Konstan MW, Nair N, Zhu J, Arteaga-Solis E, Van Goor F, McGarry L, Prieto-Centurion V, Sosnay PR, Bozic C, Waltz D, Mayer-Hamblett N. Zemanick ET, et al. Among authors: taylor cousar jl. J Cyst Fibros. 2025 Jan 3:S1569-1993(24)01854-X. doi: 10.1016/j.jcf.2024.12.006. Online ahead of print. J Cyst Fibros. 2025. PMID: 39755444 Free article.
Research Priorities in Pediatric Asthma Morbidity: Addressing the Impacts of Systemic Racism on Children with Asthma in the United States. An Official American Thoracic Society Workshop Report.
Lovinsky-Desir S, Riley IL, Bryant-Stephens T, De Keyser H, Forno E, Kozik AJ, Louisias M, Matsui EC, Sheares BJ, Thakur N, Apter AJ, Beck AF, Bentley-Edwards KL, Berkowitz C, Braxton C, Dean J, Jones CP, Koinis-Mitchell D, Okelo SO, Taylor-Cousar JL, Teach SJ, Wechsler ME, Gaffin JM, Federico MJ. Lovinsky-Desir S, et al. Among authors: taylor cousar jl. Ann Am Thorac Soc. 2024 Oct;21(10):1349-1364. doi: 10.1513/AnnalsATS.202407-767ST. Ann Am Thorac Soc. 2024. PMID: 39352175 Free PMC article.
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL. Jain R, et al. Among authors: taylor cousar jl. Chest. 2024 Sep 27:S0012-3692(24)05275-9. doi: 10.1016/j.chest.2024.09.019. Online ahead of print. Chest. 2024. PMID: 39343292
Reflections 5 years on from the approval of ETI therapy.
Middleton PG, Taylor-Cousar JL. Middleton PG, et al. Among authors: taylor cousar jl. Lancet Respir Med. 2024 Oct;12(10):752-754. doi: 10.1016/S2213-2600(24)00259-5. Epub 2024 Sep 23. Lancet Respir Med. 2024. PMID: 39326425 No abstract available.
132 results